Life sciences continues to boom as the industry’s revenue is forecast to grow to $10 billion in the next five years, and it’s all green lights for property investors.
Superannuation funds and offshore capital are diving into the life sciences property sector, according to a report commissioned by Colliers and Harrison Street, while developers compete for prized land close to medical precincts.
The life sciences alternative asset class includes biotechnology, pharmaceuticals, biomedical technologies, healthcare technologies and medical equipment, botanical science, and environmental sciences.
TUD+ Member Only Content
Sign in to your TUD+ Account or join 50,000 property professionals who stay up to date with our newsletters and market trends with Australia's most trusted property journalists.